(Q44069742)

29 November 2017

title

Effects of orlistat on fat-soluble vitamins in obese adolescents (English)

1 reference

29 November 2017

0 references

1 reference

5

1 reference

29 November 2017

4

Gabriel I Uwaifo

1 reference

29 November 2017

Jennifer R McDuffie

1

1 reference

29 November 2017

Karim A Calis

series ordinal

2

1 reference

29 November 2017

Sarah L Booth

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

22

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

814-822

1 reference

First clinical studies with orlistat: a short review

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Orlistat: a review of its use in the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

An investigation into a possible relationship between vitamin D, parathyroid hormone, calcium and magnesium in a normally pigmented and an albino rural black population in the Northern Province of South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Assessment of colorimetric enzymatic determination of triglyceride, by manual and centrifugal analyzer techniques, and comparison with a CDC standardized method

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Increased skin pigment reduces the capacity of skin to synthesise vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Racial pigmentation and the cutaneous synthesis of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

Measurement of lipid-soluble vitamins-further adjustment needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.814.33627

10.1592/PHCO.22.11.814.33627

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference